76.38
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $76.38, with a volume of 4.38M.
It is up +1.41% in the last 24 hours and down -5.91% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$75.32
Open:
$75.84
24h Volume:
4.38M
Relative Volume:
1.17
Market Cap:
$50.05B
Revenue:
$77.08B
Net Income/Loss:
$3.40B
P/E Ratio:
16.21
EPS:
4.711
Net Cash Flow:
$15.15B
1W Performance:
-3.17%
1M Performance:
-5.91%
6M Performance:
+0.57%
1Y Performance:
-8.71%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PUK, PRU
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
76.38 | 49.36B | 77.08B | 3.40B | 15.15B | 4.711 |
|
MFC
Manulife Financial Corp
|
38.04 | 62.68B | 42.06B | 4.30B | 21.81B | 2.2533 |
|
AFL
Aflac Inc
|
117.15 | 60.93B | 17.13B | 3.65B | 2.57B | 6.8862 |
|
PUK
Prudential Plc Adr
|
32.63 | 40.42B | 21.69B | 3.60B | 1.36B | 2.5833 |
|
PRU
Prudential Financial Inc
|
102.80 | 34.93B | 57.61B | 2.86B | 5.27B | 7.2959 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
MetLife, Inc. (NYSE:MET) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MetLife Q4 Earnings Call Highlights - Yahoo Finance
MetLife, Inc. (NYSE:MET) Q4 2025 Earnings Call Transcript - Insider Monkey
‘There’s no demand for labor’ – MetLife’s Drew Matus - Seeking Alpha
MetLife stock outlook: Is Wall Street bullish or bearish? - MSN
Piper Sandler Adjusts Price Target on MetLife to $81 From $84, Maintains Neutral Rating - marketscreener.com
Wolfe Research Adjusts Price Target on MetLife to $89 From $91, Maintains Outperform Rating - marketscreener.com
Is MetLife Inc the Safest Flex on Wall Street Right Now? Real Talk on MET - AD HOC NEWS
MetLife Broadens Upwise Reach Through Nayya and Workday Deal - MSN
Envestnet Asset Management Inc. Sells 448,986 Shares of MetLife, Inc. $MET - MarketBeat
MetLife Q4 2025 slides: Earnings exceed targets as investment management soars By Investing.com - Investing.com Nigeria
MetLife Inc (MET) Q4 2025 Earnings Call Highlights: Strong Finan - GuruFocus
6 Analysts Have This To Say About MetLife - Benzinga
MetLife Tops Fortune List As Investors Weigh Mixed Earnings Picture - Yahoo Finance
MetLife Q4 Earnings Beat Estimates on Increasing Volumes - Yahoo Finance
Barclays Adjusts Price Target on MetLife to $92 From $90, Maintains Overweight Rating - marketscreener.com
MetLife (MET) Reports Strong 2025 Earnings and Strategic Progres - GuruFocus
Higher Private Equity Returns Help Fuel Jump in MetLife Profit - Bloomberg.com
Earnings call transcript: MetLife Q4 2025 earnings beat EPS forecasts By Investing.com - Investing.com India
UBS Adjusts Price Target on MetLife to $98 From $94, Maintains Buy Rating - marketscreener.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
MetLife Recognized As Industry Leader on Fortune World’s Most Admired Companies™ 2026 List - accessnewswire.com
MetLife Recognized As Industry Leader on Fortune World's Most Admired Companies(TM) 2026 List - marketscreener.com
Principal Financial Group Inc. Sells 20,017 Shares of MetLife, Inc. $MET - MarketBeat
ABN AMRO Bank N.V. Purchases 36,950 Shares of MetLife, Inc. $MET - MarketBeat
MetLife (MET) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
MetLife Inc (NYSE:MET) Reports Strong Q4 2025 Earnings Beat Despite Revenue Miss - Chartmill
MetLife Reports Strong 2025 Results and Growth Momentum - TipRanks
Insurer MetLife adjusted quarterly profit rises on strong investment returns By Reuters - Investing.com
MetLife (NYSE:MET) Announces Earnings Results, Beats Expectations By $0.20 EPS - MarketBeat
MetLife Q4 earnings strengthened by Group Benefits, RIS units (MET:NYSE) - Seeking Alpha
Insurer MetLife adjusted quarterly profit rises on strong investment returns - Reuters
Insurer MetLife Adjusted Quarterly Profit Rises on Strong Investment Returns - US News Money
MetLife Q4 Adjusted Earnings, Revenue Rise - marketscreener.com
MetLife Inc. Reveals Drop In Q4 Profit - Nasdaq
MetLife (NYSE:MET) Misses Q4 CY2025 Revenue Estimates - TradingView
MetLife Announces Full Year and 4Q 2025 Results - Business Wire
MetLife CFO John McCallion Provides Fourth Quarter and Full Year 2025 Financial Update Video - The Joplin Globe
MetLife earnings on deck: Can Asia growth offset credit headwinds? By Investing.com - Investing.com Nigeria
MetLife earnings on deck: Can Asia growth offset credit headwinds? - Investing.com
MetLife, Inc. $MET Position Decreased by Federated Hermes Inc. - MarketBeat
Does MetLife’s Earnings Beat Projections Enough To Reinforce Its Growth Story For MET Investors? - simplywall.st
Aug Final Week: Does MetLife Inc align with a passive investing strategyJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Will These 4 Insurance Stocks Insure a Q4 Earnings Beat? - TradingView
MetLife, Inc. (MET) Balances Analyst Downgrade with Global Growth and Strategic Opportunities - Finviz
MetLife, Inc. (MET) balances analyst downgrade with global growth and strategic opportunities - MSN
Libertex adds MetLife and biotech stocks to CFD lineup - Traders Union
AGF Management Ltd. Increases Stake in MetLife, Inc. $MET - MarketBeat
MetLife (MET) Reports Earnings Tomorrow: What To Expect - Finviz
MetLife Earnings Report Q4 2025: Revenue Growth & Analyst ExpectationsNews and Statistics - IndexBox
MetLife named No. 1 in Life and Health Insurance on Fortune List - The Himalayan Times
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):